MedTrace Logo

Stimulant Use and Methylation in HIV

NCT05916989 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2023-11-02

No results posted yet for this study

Summary

This study will leverage extracted leukocyte DNA specimens from a completed NIH-funded project to examine the efficacy of a behavioral intervention model that reduced stimulant use on DNA methylation over 6 months.

Conditions

  • HIV Infections
  • Methamphetamine-dependence
  • Methamphetamine Abuse

Sponsors & Collaborators

Principal Investigators

  • Adam W Carrico, PhD · Florida International University

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-30
Primary Completion
2022-10-26
Completion
2022-10-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05916989 on ClinicalTrials.gov